Admedus taps investors for $18m

29/07/2016 - 13:35

Bookmark

Upgrade your subscription to use this feature.

Biotech firm Admedus has tapped investors for $18.3 million to fund ongoing development of its medical technologies.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options